Despite its normal transcription level in either pathology, a recent study found the enzyme to affect invasion and metastasis of hepatocellular carcinoma via SMAD6 gene [49], whereas it also regulates AKT/ERK1/2 signaling critical for angiogenesis of glioblastoma [50]. This evidence concerns the gene MAPK3 and hepatocellular carcinoma.